The results report for urine supersaturation testing contains multiple data points. In this test-specific episode of the "Answers From the Lab" podcast, John Lieske, M.D., explains how Mayo Clinic Laboratories is making it easier for clinicians to interpret this complex information and better care for patients with kidney stones.

"These test results can really be important clues to diagnosis and treatment options," Dr. Lieske says. "But it's a somewhat complicated set of numbers. We're trying to make these results much more intuitive to providers."

The updated results report includes graphics that highlight key numbers and trends, as well as interpretive comments. It also includes an explanatory guide to what the test measures and the importance of those measurements to kidney stone disease.

"Kidney stones are quite common. But getting the most information from these reports can be daunting," Dr. Lieske says. "This updated results report will be very helpful for people who don't have a lot of experience with interpreting these tests."

Listen to learn more about Mayo Clinic Laboratories' updated results report for urine supersaturation testing.

Note: Podcasts will not playback on Internet Explorer. Please use an alternative web browser, or listen from your mobile device on a preferred listening app.

Testing

SUP24 | Supersaturation Profile, 24 Hour, Urine

• Identifies urinary supersaturations that increase the risk of specific types of stones.
• Identifies specific urine abnormalities that increase overall saturation.
• Aids accurate treatment plan development.
• Monitors treatment effectiveness.
• Aids in reducing stone recurrences.

SSH24 | Supersaturation Profile, Self-Collect, 24 Hour, Urine

• Similar to SUP24, but allows for at-home collection to conveniently facilitate a complete collection and help ensure optimal results. 
• Upon ordering, patient’s address will be entered, and the collection kit sent directly to the patient’s home for collection. In addition to necessary testing equipment, the kit includes a pre-paid shipping container to send sample directly to Mayo Clinic Laboratories

*Note: Clients must contact Mayo Clinic Laboratories prior to order to establish home collection service.

SUPRA | Supersaturation Profile, Random, Urine

• Particularly helpful for pediatric patients when 24-hour urine collection is not possible.
• Identifies urinary supersaturations that increase the risk of specific types of stones.
• Identifies specific urine abnormalities that increase overall saturation.
• Aids accurate treatment plan development.
• Monitors treatment effectiveness.
• Aids in reducing stone recurrences.

The latest

Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC

September 24, 2024

Matthew J. Schultz, Ph.D., and Amy L. White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD-related peripheral neuropathy is fairly common.

Panel Detects Demyelinating Neuropathy Biomarkers: John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S.

September 17, 2024

John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating autoimmune conditions.

Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

September 10, 2024

Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' unique genetic tests identify patients at high risk of severe reactions to fluoropyrimidines — a type of chemotherapy drug. Test results can guide clinical decision-making for safer cancer treatment.

View MoreView Less